Pfizer Japan Plans Network To Share Info With Academics, Researchers
This article was originally published in PharmAsia News
Executive SummaryPfizer Japan has established a system to make itself available to scientists and others to collaborate on drug research and development
You may also be interested in...
As part of its response to the coronavirus outbreak, the European association representing generic and biosimilar drug companies, Medicines for Europe, has set out a series of policy recommendations that it says could help to mitigate the possible risks to medicines supply.